Jagust WJ - Search Results

1

The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.

Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. Jagust WJ, et al. Alzheimers Dement. 2015 Jul;11(7):757-71. doi: 10.1016/j.jalz.2015.05.001. Alzheimers Dement. 2015. PMID: 26194311 Free PMC article. Review.

2

Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.

Mathis CA, Bishop JE, Gerdes JM, Whitney JM, Brennan KM, Jagust WJ. Mathis CA, et al. Among authors: jagust wj. Int J Rad Appl Instrum B. 1992 Jul;19(5):571-88. doi: 10.1016/0883-2897(92)90153-p. Int J Rad Appl Instrum B. 1992. PMID: 1399687

3

Diminished glucose transport in Alzheimer's disease: dynamic PET studies.

Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF. Jagust WJ, et al. J Cereb Blood Flow Metab. 1991 Mar;11(2):323-30. doi: 10.1038/jcbfm.1991.65. J Cereb Blood Flow Metab. 1991. PMID: 1997504

4

Regional cerebral glucose transport and utilization in Alzheimer's disease.

Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF. Friedland RP, et al. Among authors: jagust wj. Neurology. 1989 Nov;39(11):1427-34. doi: 10.1212/wnl.39.11.1427. Neurology. 1989. PMID: 2812318

5

Longitudinal studies of regional cerebral metabolism in Alzheimer's disease.

Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B. Jagust WJ, et al. Neurology. 1988 Jun;38(6):909-12. doi: 10.1212/wnl.38.6.909. Neurology. 1988. PMID: 3259296

6

Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease.

Wolfe N, Reed BR, Eberling JL, Jagust WJ. Wolfe N, et al. Among authors: jagust wj. Arch Neurol. 1995 Mar;52(3):257-62. doi: 10.1001/archneur.1995.00540270049018. Arch Neurol. 1995. PMID: 7872878

7

In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine.

Jagust WJ, Eberling JL, Roberts JA, Brennan KM, Hanrahan SM, VanBrocklin H, Enas JD, Biegon A, Mathis CA. Jagust WJ, et al. Eur J Pharmacol. 1993 Sep 28;242(2):189-93. doi: 10.1016/0014-2999(93)90079-w. Eur J Pharmacol. 1993. PMID: 8253114

8

[125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats.

Biegon A, Mathis CA, Hanrahan SM, Jagust WJ. Biegon A, et al. Among authors: jagust wj. Brain Res. 1993 Aug 13;619(1-2):236-46. doi: 10.1016/0006-8993(93)91617-2. Brain Res. 1993. PMID: 8374782

9

Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology.

Jagust WJ. Jagust WJ. Ann N Y Acad Sci. 1996 Jan 17;777:30-6. doi: 10.1111/j.1749-6632.1996.tb34398.x. Ann N Y Acad Sci. 1996. PMID: 8624103 Review.

10

Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter.

Jagust WJ, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, Hanrahan SM, Roberts JA, Brennan KM, Mathis CA. Jagust WJ, et al. J Nucl Med. 1996 Jul;37(7):1207-14. J Nucl Med. 1996. PMID: 8965200 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

718 results

Search Page

Filters